V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007853 | 250005450 | 0 | 0 | Disease modification (D) | 2014-12-01 | 2014-12-01 | PACLITAXEL | N | N | 250001102 | GEMCARBO |
| 250007854 | 250005450 | 1.82 | 75.2 | Palliative (P) | 2017-01-28 | 2017-02-03 | Trial Unspecified | N | null | 250001102 | CHOP R |
| 250007855 | 250005450 | null | 60 | Palliative (P) | 2018-05-10 | 2018-05-10 | IPM | 01 | N | 250001102 | TRIAL |
| 250007856 | 250005451 | 1.55 | 93.4 | Curative (C) | 2018-05-28 | 2018-06-03 | Pemetrexed | N | N | 250001259 | PEMETREXED |
| 250007857 | 250005452 | 1.85 | 63.4 | Palliative (P) | 2018-01-03 | 2018-01-03 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 250001268 | GEMCARBO |
| 250007858 | 250009852 | 1.59 | 102 | Disease modification (D) | null | 2017-05-12 | GEMCARBO | Y | N | 250001417 | EOX |
| 250007859 | 250005453 | 1.79 | 120 | Curative (C) | 2017-11-04 | 2017-11-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250001462 | TRIAL |
| 250007860 | 250005454 | 1.65 | 91.8 | Palliative (P) | 2015-06-02 | 2015-06-02 | Pemetrexed | 2 | N | 250001544 | PEMETREXED |
| 250007861 | 250005455 | 1.65 | 75.6 | Palliative (P) | 2018-11-20 | 2018-11-20 | Cytarabine Low Dose | 2 | N | 250001559 | CARBOPLATIN |
| 250007862 | 250005455 | 1.71 | 80 | Curative (C) | 2018-05-28 | 2018-06-03 | Vinorelbine IV | 02 | N | 250001559 | CARBOPLATIN + VINORELBINE |
| 250007863 | 250005456 | 1.77 | 86 | Disease modification (D) | 2016-10-20 | 2016-10-20 | Pemetrexed | 02 | N | 250001797 | PEMETREXED |
| 250007864 | 250005456 | null | null | Disease modification (D) | 2016-01-05 | 2016-01-11 | Vincristine (weekly) | N | N | 250001797 | CISPLATIN + GEMCITABINE |
| 250007865 | 250005456 | 1.55 | 54.6 | Palliative (P) | null | 2014-12-03 | Cisplatin + Paclitaxel | N | N | 250001797 | PEMETREXED |
| 250007866 | 250005457 | 1.74 | null | Palliative (P) | null | 2017-12-23 | BENDAMUSTINE + RITUXIMAB | 1 | N | 250001925 | GEMCARBO |
| 250007867 | 250005458 | 1.55 | 72 | Disease modification (D) | 2017-08-30 | 2017-08-30 | Azacitidine | N | N | 250002074 | TRIAL |
| 250007868 | 250005458 | null | 72 | Curative (C) | null | 2017-08-08 | RUXOLITINIB | N | N | 250002074 | IPM |
| 250007869 | 250005459 | 1.74 | 0 | Palliative (P) | 2018-03-31 | 2018-03-31 | Pemetrexed | N | N | 250002158 | VINORELBINE |
| 250007870 | 250005460 | null | 85 | Palliative (P) | 2015-04-13 | 2015-04-19 | Trial Unspecified | N | null | 250002205 | IPM |
| 250007871 | 250005461 | null | 67.1 | Curative (C) | 2018-12-22 | 2018-12-28 | CARBOPLATIN + GEMCITABINE | 02 | N | 250002253 | PEMETREXED |
| 250007872 | 250005462 | 1.67 | 0 | Disease modification (D) | 2016-02-04 | 2016-02-14 | Vinorelbine (oral) | N | N | 250002368 | IPM |
| 250007873 | 250005462 | 0 | null | Curative (C) | 2016-12-03 | 2017-01-17 | CARBOPLATIN | N | N | 250002368 | IPM |
| 250007874 | 250005462 | 1.75 | null | Palliative (P) | 2017-12-05 | 2017-12-05 | Temozolomide 150mg/m2 | 01 | N | 250002368 | CARBOPLATIN |
| 250007875 | 250005463 | null | null | null | 2018-05-23 | 2018-05-30 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 250002469 | CYTARABINE |
| 250007876 | 250005463 | 0 | 0 | Disease modification (D) | 2015-08-27 | 2015-08-27 | Cisplatin + Vinorelbine (PO) | N | N | 250002469 | CVP R |
| 250007877 | 250005464 | 1.77 | 62.3 | Disease modification (D) | 2015-05-08 | 2015-05-08 | FLAG + Idarubicin | N | N | 250002533 | TRIAL |
| 250007878 | 250005465 | 1.6 | null | Palliative (P) | 2018-07-18 | 2018-07-18 | VINORELBINE | 02 | N | 250002551 | PEMETREXED |
| 250007879 | 250005465 | null | 76 | Disease modification (D) | 2010-11-27 | 2014-11-03 | Bevacizumab 7.5mg/kg | N | null | 250002551 | TRIAL |
| 250007880 | 250011658 | 1.85 | null | null | 2017-01-01 | 2017-01-01 | AFLIBERCEPT + FU + IRINOTECAN | null | N | 250002708 | PEMETREXED |
| 250007881 | 250011658 | 0 | 0 | Palliative (P) | 2018-02-24 | 2018-02-24 | Vinorelbine (oral) | 02 | N | 250002708 | GEMCARBO |
| 250007882 | 250011658 | 1.67 | 69 | Disease modification (D) | 2016-08-25 | 2016-08-25 | RUXOLITINIB | 02 | N | 250002708 | PEMETREXED |
| 250007883 | 250005466 | 1.77 | 0 | Disease modification (D) | 2017-06-22 | 2017-06-22 | Pemetrexed | N | N | 250003155 | NOT MATCHED |
| 250007884 | 250005467 | 1.67 | null | Curative (C) | 2016-07-05 | 2016-07-07 | EC | 02 | N | 250003309 | TRIAL |
| 250007885 | 250005468 | 1.82 | null | null | 2018-07-13 | 2018-07-13 | CARBOPLATIN | N | null | 250003319 | CVP R |
| 250007886 | 250005469 | 1.55 | 0 | Palliative (P) | 2016-12-26 | 2016-12-26 | CARBOPLATIN + ETOPOSIDE | 02 | N | 250003404 | OXALIPLATIN + MDG |
| 250007887 | 250005470 | 1.65 | 85 | Palliative (P) | 2015-06-21 | 2015-07-09 | Pemetrexed | Y | N | 250003410 | TRIAL |
| 250007888 | 250005471 | 1.52 | 51.6 | Neo-adjuvant (N) | 2018-01-29 | 2018-03-02 | Busulfan Oral | 2 | N | 250003443 | TRIAL |
| 250007889 | 250005471 | null | 91.6 | null | 2018-04-20 | 2018-04-30 | Gemcitabine 1000mg/m2 D1 8 15 | null | N | 250003443 | CISPLATIN + GEMCITABINE |
| 250007890 | 250005472 | 0 | 85.6 | Curative (C) | 2016-10-22 | 2016-11-13 | Cisplatin | 2 | N | 250003575 | TRIAL |
| 250007891 | 250009860 | 1.73 | null | Disease modification (D) | 2016-03-22 | 2016-03-22 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 250003601 | SCOT TRIAL |
| 250007892 | 250005473 | 1.65 | null | null | 2013-08-04 | 2014-12-09 | Cisplatin | N | N | 250003618 | IMATINIB |
| 250007893 | 250005473 | 1.7 | null | Palliative (P) | 2016-07-06 | 2016-07-06 | Ipilimumab | 02 | N | 250003618 | AFLIBERCEPT + FU + IRINOTECAN |
| 250007894 | 250005474 | 1.69 | 64.3 | Disease modification (D) | 2019-02-13 | 2019-02-13 | Trial Unspecified | 02 | N | 250003762 | CISPLATIN + RT |
| 250007895 | 250005474 | 1.63 | 0 | Palliative (P) | 2017-10-10 | 2017-10-24 | Vinorelbine (oral) | N | N | 250003762 | CARBOPLATIN + PACLITAXEL |
| 250007896 | 250005475 | 1.74 | 0 | Palliative (P) | 2014-03-09 | 2014-03-10 | Pemetrexed | N | N | 250003917 | CYTARABINE |
| 250007897 | 250009863 | 1.74 | 79.9 | Curative (C) | 2013-06-11 | 2013-06-12 | RUXOLITINIB | 02 | null | 250003954 | BUSULPHAN |
| 250007898 | 250009863 | null | 68 | Palliative (P) | 2017-06-29 | 2017-07-01 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 250003954 | IPM |
| 250007899 | 250009863 | 1.83 | 71.9 | Disease modification (D) | 2015-09-27 | 2015-09-27 | CISPLATIN + Ganetespib + Ganetespib + PEMETREXED | N | N | 250003954 | PEMETREXED |
| 250007900 | 250005476 | 1.75 | null | Disease modification (D) | 2017-12-29 | 2017-12-31 | Trial Unspecified | N | N | 250004017 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250007901 | 250005477 | 1.74 | null | Curative (C) | 2018-02-05 | 2018-03-11 | Rituximab | N | N | 250004027 | AZACITIDINE |
| 250007902 | 250009864 | 0 | 69 | Palliative (P) | 2015-09-09 | 2015-09-09 | Rituximab | 2 | N | 250004138 | IPM |